CHI's Optimizing Bioassays for Biologics

Organization: Cambridge Healthtech Institute

Venue: Hyatt Regency Washington DC

Location: Washington, Washington, United States

Event Date/Time: Nov 12, 2013 End Date/Time: Nov 13, 2013
Report as Spam

Description

Bioassays are a critical component of biologics drug discovery and development. However, ever-changing technology, approaches, and regulatory requirements make it difficult to keep projects on track and on budget. Cambridge Healthtech Institute’s Inaugural Optimizing Bioassays for Biologics will bring together key individuals from bioanalytical R&D, cell and antibody engineering, immunology, pharmacology, and preclinical and clinical development. Special focus will be given to the development and validation of potency assays, developing bioassays for multi-domain proteins, and establishing a standard for using cell-based vs. non-cell-based assays. Regulatory updates, expectations for novel constructs, and reference standards will also be shared. This conference is part of Immunogenicity Summit 2013.

 

Venue

400 New Jersey Ave NW
Washington
Washington
United States
MORE INFO ON THIS VENUE

Organizations

Cambridge Healthtech Institute